The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case–control study

Purpose To evaluate the resolution time and the recurrence rate of acute central serous chorioretinopathy (CSC) after spontaneous resolution and low-fluence photodynamic therapy (PDT). Methods Case–control study: The CSC patients who were admitted to our clinic for the first time were included. No t...

Full description

Saved in:
Bibliographic Details
Published in:Eye (London) 2016-07, Vol.30 (7), p.1005-1010
Main Authors: Ozkaya, A, Alkin, Z, Ozveren, M, Yazici, A T, Taskapili, M
Format: Article
Language:English
Subjects:
692/699/3161/3175
692/700/565/1436
Acute Disease
Adult
Case-Control Studies
Central Serous Chorioretinopathy - diagnosis
Central Serous Chorioretinopathy - drug therapy
Central Serous Chorioretinopathy - physiopathology
Clinical Study
Coloring Agents - administration & dosage
Female
Fluorescein Angiography
Humans
Indocyanine Green - administration & dosage
Laboratory Medicine
Male
Medicine
Medicine & Public Health
Middle Aged
Ophthalmology
Pharmaceutical Sciences/Technology
Photochemotherapy
Photosensitizing Agents - therapeutic use
Porphyrins - therapeutic use
Recurrence
Remission, Spontaneous
Retrospective Studies
Surgery
Surgical Oncology
Time Factors
Visual Acuity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To evaluate the resolution time and the recurrence rate of acute central serous chorioretinopathy (CSC) after spontaneous resolution and low-fluence photodynamic therapy (PDT). Methods Case–control study: The CSC patients who were admitted to our clinic for the first time were included. No treatment was given during the first 6 months. Patients were treated with PDT after 6 months from the initial signs of the disease, if they did not show any sign of resolution. The patients who showed a significant decrease in subretinal fluid after month 6 were not scheduled for PDT. The primary outcomes were the resolution time and the recurrence rate after the first episode. Secondary outcome measures were the change in BCVA and CRT during the follow up. Results A total of 77 consecutive eyes of 77 patients were included, 41 eyes (53.2%) with spontaneously resolved CSC and 36 eyes (46.8%) with PDT-treated CSC. The initial resolution time was 4.1±3.2 months in spontaneous resolution group, and 8.1±0.8 months in PDT group, respectively ( P
ISSN:0950-222X
1476-5454
DOI:10.1038/eye.2016.79